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Milk cholesterol concentration 
in mice is not affected by high 
cholesterol diet- or genetically-
induced hypercholesterolaemia
Lidiya G. Dimova  , Mirjam A. M. Lohuis  , Vincent W. Bloks, Uwe J. F. Tietge &  
Henkjan J. Verkade
Breast milk cholesterol content may imply to affect short- and long-term cholesterol homeostasis 
in the offspring. However, mechanisms of regulating milk cholesterol concentration are only partly 
understood. We used different mouse models to assess the impact of high cholesterol diet (HC)- or 
genetically-induced hypercholesterolaemia on milk cholesterol content. At day 14 postpartum we 
determined milk, plasma and tissue lipids in wild type (WT), LDL receptor knockout (Ldlr−/−), and 
ATP-binding cassette transporter G8 knockout (Abcg8−/−) mice fed either low- or 0.5% HC diet. In 
chow-fed mice, plasma cholesterol was higher in Ldlr−/− dams compared to WT. HC-feeding increased 
plasma cholesterol in all three models compared to chow diet. Despite the up to 5-fold change in 
plasma cholesterol concentration, the genetic and dietary conditions did not affect milk cholesterol 
levels. To detect possible compensatory changes, we quantified de novo cholesterol synthesis in 
mammary gland and liver, which was strongly reduced in the various hypercholesterolaemic conditions. 
Together, these data suggest that milk cholesterol concentration in mice is not affected by conditions of 
maternal hypercholesterolaemia and is maintained at stable levels via ABCG8- and LDLR-independent 
mechanisms. The robustness of milk cholesterol levels might indicate an important physiological 
function of cholesterol supply to the offspring.
Breast milk contains high levels of cholesterol (0.23–0.39 mmol/L) in contrast to most infant formulas 
(0–0.10 mmol/L)1–3. The relatively high cholesterol concentration in breast milk has been suggested to have a 
lasting impact on the cholesterol homeostasis of the offspring1,4. Breast-fed offspring has high plasma cholesterol 
levels in early life, but lower plasma cholesterol in adulthood, compared to formula-fed individuals1,5. The lower 
plasma cholesterol concentrations in adulthood may relate to long-term cardio-protective effects of breast milk, 
in accordance with the metabolic programming hypothesis1,6. Additionally, we recently demonstrated that mater-
nal ezetimibe-induced lower dietary cholesterol bioavailability during the lactation period in mice decreases 
cholesterol absorption in the offspring up to adulthood through decreased intestinal NPC1L1 expression7.
The mechanisms involved in the regulation of milk cholesterol concentration are only partly understood. With 
the recent cardiometabolic disease pandemic, dyslipidaemia and disturbances in lipid homeostasis are becoming 
increasingly common conditions in pregnant and lactating women8,9. Maternal hypercholesterolaemia during 
gestation has been associated with increased plasma cholesterol in the fetus10,11. However, it remains unclear 
to what extent maternal hypercholesterolaemia, either caused by genetic or dietary factors, impacts cholesterol 
transport across the mammary gland and affects cholesterol concentration in milk with possible effects in the 
offspring.
Cholesterol in milk can originate from different sources. The predominant fraction of cholesterol reaches the 
milk via plasma12: either from preformed stores, from dietary origin or from de novo synthesis in either the mam-
mary gland epithelium cells13,14 or the liver12. The detailed transport route by which cholesterol in the circulation 
is taken up by the mammary gland has not been identified. There have been reports suggesting an ApoB-mediated 
uptake of cholesterol-containing lipoproteins15. Several receptors for uptake of cholesterol-rich apolipoprotein 
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B-containing lipoproteins are abundantly expressed in the mammary epithelial cells, amongst which LDL-, 
VLDL- and CD36-receptors14. Other lipoproteins found in plasma, like the high-density lipoproteins, may serve 
as an alternative source for cholesterol uptake since scavenger receptors from the CD36 family are also expressed 
in the mammary epithelium16. In addition, mammary gland epithelial cells express cholesterol efflux transporters, 
such as ATP-binding cassette (ABC) transporters ABCG5/ABCG8, ABCA1, and ABCG1, whose expressions 
fluctuate depending on lactation stage17–19 and could possibly impact cholesterol levels in the milk.
We aimed to address the relationship between maternal hypercholesterolaemia and milk cholesterol concen-
tration in mouse models. We analysed milk cholesterol concentrations in lactating mice with hypercholestero-
laemia of different severity, induced by dietary and/or genetic manipulations. The dietary means to manipulate 
plasma cholesterol concentrations consisted of feeding a high-cholesterol diet (0.5% w/w), while genetic manip-
ulation involved the ablation of either the Abcg8 or the Ldlr gene. The ABC cassette G8 protein is a cholesterol 
transporter primarily expressed on the apical membrane of hepatocytes and enterocytes, where it facilitates 
export of cholesterol20. Interestingly, Abcg8 is also moderately expressed in the lactating bovine mammary gland 
and in the murine mammary gland, as demonstrated in literature and online databases17,19,21. The LDL-receptor 
is the dominant transport protein involved in the uptake of apoB100-containing lipoproteins from the plasma22, 
and highly expressed in murine mammary gland21. Humans with genetic loss of LDLR function have a severe 
hypercholesterolaemia that is further increased upon dietary cholesterol exposure23. We assessed the potential 
relevance of cholesterol secretion into milk via the ABCG8 transporter and via mammary gland uptake of cho-
lesterol via the LDL receptor. To assess possible variation in the origin of milk cholesterol in the different models 
of hypercholesterolaemia, we measured de novo cholesterol synthesis in the liver and mammary gland, using 
deuterated water methodology.
Results
High-cholesterol diet increases plasma and hepatic cholesterol levels. To assess the isolated effect 
of ABCG8- or LDLR-deficiency we first measured cholesterol levels in plasma of dams on a chow diet. While 
ABCG8-deficiency did not affect basal plasma cholesterol, the LDLR-deficient dams displayed marked hyper-
cholesterolaemia (5.2-fold change, p < 0.01, Fig. 1a), mostly due to increased cholesterol levels in LDL and VLDL 
(Fig. 1b–d). Feeding the dams high cholesterol (HC) diet increased the levels of total plasma cholesterol in all 
models (Fig. 1a). The size of the effect reached maximum in the Ldlr−/− mice (4.8-fold change, p < 0.01) fol-
lowed by Abcg8−/− (2-fold change, p < 0.05) and wild-type (1.5-fold change, p < 0.05). On chow diet, hepatic 
cholesterol concentration corresponded with the differences in the plasma cholesterol levels: similar levels in 
wild-type and Abcg8 knockout mice and 0.6-fold higher in LDLR-deficient mice (p < 0.01). The HC diet increased 
the cholesterol accumulation in the hepatic tissues of all dams (p < 0.05, Fig. 2). On the HC diet, however, the 
hepatic cholesterol concentrations did not differ significantly between the three models.
Milk cholesterol levels are independent of plasma, liver and mammary gland cholesterol lev-
els. We then determined whether the hypercholesterolaemia was associated with increased cholesterol content 
of the mammary glands. On chow diet there were no differences in mammary cholesterol content between geno-
types, despite the significantly increased plasma cholesterol levels in Ldlr−/− mice (Fig. 3a). The HC diet did not 
increase mammary cholesterol content in the WT mice, in contrast to the Abcg8 and Ldlr knockout mice (+39%, 
p < 0.05; and +62%, p < 0.01 respectively; Fig. 3a). Interestingly, the HC diet-induced hypercholesterolaemia 
did not affect the milk cholesterol concentrations in any of the three models, with milk cholesterol levels ranging 
between 1.7–2.3 mM (interquartile range) (Fig. 3b).
In order to analyse the possible association between milk cholesterol levels and plasma and mammary gland 
cholesterol levels and nest size, we performed regression analysis. Nest sizes (range: 2–8 pups) were not correlated 
with milk cholesterol levels. Cholesterol levels in mammary gland tissue were strongly and positively related to 
plasma cholesterol levels in all three models (WT r2 = 0.54, p = 0.016; Abcg8−/− r2 = 0.61, p = 0.013; Ldlr−/− 
r2 = 0.51, p = 0.0096). In none of the three groups were plasma and milk cholesterol levels significantly correlated. 
Ratios of VLDL + LDL to HDL cholesterol as calculated from FPLC fractions (Fig. 1e) were also unrelated to milk 
cholesterol levels.
De novo cholesterol synthesis is strongly decreased in high cholesterol-fed mice. The increased 
plasma, hepatic and mammary gland cholesterol levels in the hypercholesterolaemic models did not translate 
into increased milk cholesterol concentrations. We then tested the possibility that the stable concentrations were 
obtained by suppression of systemic or local cholesterol synthesis. In all chow-fed groups there was de novo 
hepatic and mammary gland cholesterol synthesis (Fig. 4). Feeding the HC diet strongly reduced the cholesterol 
synthesis rate in liver (Fig. 4a) and mammary gland (Fig. 4b) in all three models.
Next, we used linear regression analysis to assess the possible relationship between the de novo synthesis in 
mammary gland and the milk cholesterol concentration. The milk cholesterol levels did not correlate with the 
fraction of de novo synthesized cholesterol in mammary gland in any of the three groups (WT r2 = 0.03, p = 0.66; 
Abcg8−/− r2 = 0.07, p = 0.51; Ldlr−/− r2 = 0.05, p = 0.64).
Discussion
We addressed the relationship between maternal hypercholesterolaemia, induced by dietary or genetic means, 
and milk cholesterol concentrations in mice. Our data demonstrate that milk cholesterol concentration is not 
affected by induction of severe hypercholesterolaemia and increased cholesterol levels in liver and mammary 
gland. Clearly, the ABC-cassette transporter ABCG8 and the LDL receptor do not have a critical role in defining 
milk cholesterol concentration, since their inactivation did not change it. Our data demonstrate the apparent 
robustness of milk cholesterol levels, which could support important physiological functions for the offspring.
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The milk cholesterol concentration was not affected by genetic inactivation of two candidate genes with a 
possible role in cholesterol transport towards milk, nor by high cholesterol diet-induced hypercholesterolaemia. 
This observation indicates that either the gene products are not involved, or that alternative transporting mecha-
nisms ensure redundancy in the supply of cholesterol destined for secretion into the milk. The hypothesis that the 
LDL receptor is involved in milk cholesterol transport was based on findings describing an association between 
lactation and increased mammary gland expression of LDLR in human subjects14 and high LDLR expression 
in the murine mammary gland21. In addition, lactation in rodents is characterized by an increase in circulating 
LDL24, compatible with a role for the low-density lipoproteins as a source for milk cholesterol. Our data indicate 
Figure 1. Plasma lipids. (a) Total plasma cholesterol levels were measured in whole plasma using a 
commercially available enzymatic assay (WT Chow, n = 5; WT HC, n = 5; Abcg8 −/− Chow, n = 4; Abcg8 −/− 
HC, n = 5; Ldlr −/− Chow, n = 8; Ldlr −/− HC, n = 5). Data are presented as median and interquartile range 
(Tukey). Statistical significance was tested with Kruskal-Wallis post-hoc Conover-Inman; non-different groups 
share a letter. The threshold of significance was p < 0.05. (b–d) Cholesterol in lipoprotein fractions following 
separation by FPLC of pooled plasma samples and (e) VLDL + LDL to HDL cholesterol ratios calculated from 
these results (WT Chow, n = 5; WT HC, n = 5; Abcg8 −/− Chow, n = 4; Abcg8 −/− HC, n = 5; Ldlr −/− Chow, 
n = 4; Ldlr −/− HC, n = 4). □: low cholesterol diet (Chow); ■: high cholesterol diet (HC).
www.nature.com/scientificreports/
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that uptake of cholesterol by the mammary gland can be conducted quantitatively by LDLR-independent mech-
anism(s). We cannot exclude that an alternative, LDLR-independent mechanism involves an alternative receptor 
for LDL uptake. In support of this notion, radioactivity studies in mice have shown the transfer of ApoB100 across 
the mammary epithelium towards the milk to take place at the same extent in both wild-type and LDLR-deficient 
mice15. Possibly VLDL and LRP receptors25, or even CD3626 can substitute for LDLR-deficiency. The hypothesis 
that ABCG8 is involved in milk cholesterol transport rests on the increased expression levels of the heterodi-
mer ABCG5/ABCG8 in lactating bovine mammary glands17,19, and appreciable expression of ABCG8 in murine 
mammary gland21. In hepatocytes and intestinal epithelial cells the ABCG5/ABCG8 dimer is expressed at the 
apical membrane20 where it is essential for the export of free cholesterol towards the bile and intestinal lumen, 
respectively27. Our data, however, does not support a critically important role for ABCG8 in the process of cho-
lesterol efflux across the mammary gland epithelium. The unchanged plasma cholesterol levels in Abcg8−/− mice 
on chow may be related to the fact that the diet used contained no cholesterol. Apparently neither the LDL recep-
tor nor ABCG8 is crucial for cholesterol transport towards milk in our experimental setup. In order to further 
explore the mechanistic effects of genetic ablation of LDLR and ABCG8 on milk production, additional studies 
in an in vitro model would be helpful. Unfortunately, however, there is no established reliable in vitro system for 
lactating mammary gland cells available to study alveolar mammary gland epithelial cell cholesterol transfer28.
De novo cholesterol synthesis has been shown to contribute to milk cholesterol12. For the dams, cholesterol 
demand is increased during lactation, corresponding with increased expression of cholesterol synthesis genes in 
both liver and mammary glands of bovines, rodents and humans13,14,29. We found 12-fold higher fractional cho-
lesterol synthesis rates in liver compared to mammary gland, which is in agreement with previous studies demon-
strating a larger contribution to milk cholesterol originating from hepatic than from mammary synthesis12. The 
lower mammary gland cholesterol synthesis compared with hepatic synthesis also corresponds to the expression 
levels of the Hmgcr gene in the two tissues, encoding for the rate-limiting enzyme of cholesterol synthesis13. In 
each of the three murine genotypes, dietary cholesterol supplementation strongly decreased de novo cholesterol 
synthesis in liver and in mammary gland, similarly to observations in rats30. The decreased de novo synthesis rates 
in liver and mammary gland, however, did not decrease milk cholesterol levels. The cholesterol synthesis rate is 
apparently not a critical driver for the amount of cholesterol secreted into milk. Rather, it seems that milk choles-
terol concentration is robust and “protected” against profound hypercholesterolaemia despite strongly increased 
tissue cholesterol levels. In addition, comparable to respective compensatory changes in other organs such as the 
liver, also in the mammary gland cholesterol synthesis decreased in response to dietary cholesterol feeding.
The use of whole-body inactivation of specific genes, as utilized in this study, is comprehensively asso-
ciated with systemic changes in cholesterol metabolism and apolipoprotein balance. Employing mammary 
gland-specific genetic models would exclude the influence of hepatic or intestinal deficiency in our mice. 
However, the present lack of influence on milk cholesterol concentration in whole body-knockouts does not sup-
port the possibility that organ-specific inactivation would greatly affect milk cholesterol concentrations.
We would like to hypothesize on the physiological explanation(s) of the present findings. First, it is tempting 
to speculate that the apparent robustness of the cholesterol concentration in milk relates to physiological impor-
tance in milk secretion. The importance of a stable milk cholesterol concentration could relate to the process of 
secretion of milk lipids, in particular triglycerides. Within the alveolar cells of the mammary gland the secretory 
lipids are shaped in single phospholipid layer-wrapped lipid droplets. During exocytosis the lipid droplets acquire 
an additional cholesterol-rich phospholipid bilayer, resulting in the formation of the milk-fat globule (MFG)31. 
Milk cholesterol is mainly present as unesterified cholesterol in the MFG-membrane (85–90%) and the other part 
as cholesteryl esters in the MFG-core32,33. The packaging of the lipid droplets with the MFG membrane, which 
is essential for their secretion, may therefore translate into a rather stable cholesterol content in milk, based on 
its role as an emulsion-stabilizing component as part of the MFG-membrane. Second, the robust cholesterol 
concentration in milk could also underline the hypothesized physiological function of milk cholesterol for later 
health of the offspring. In contrast to breast milk, the fat globules of common infant milk formula are smaller in 
size and differ in composition, being coated with milk proteins instead of a phospholipid and cholesterol-rich 
Figure 2. Hepatic cholesterol levels. Hepatic lipids were extracted according to Bligh & Dyer and measured 
by gas chromatography (WT Chow, n = 5; WT HC, n = 5; Abcg8 −/− Chow, n = 4; Abcg8 −/− HC, n = 5; Ldlr 
−/− Chow, n = 8; Ldlr −/− HC, n = 5). Data are presented as median and interquartile range (Tukey). □: low 
cholesterol diet (Chow); ■: high cholesterol diet (HC). Statistical significance was tested with Kruskal-Wallis 
post-hoc Conover-Inman; non-different groups share a letter. The threshold of significance was p < 0.05.
www.nature.com/scientificreports/
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membrane34,35. Indeed, infant formulas hardly contain cholesterol3. Cholesterol in early life is not considered an 
essential dietary component since infants are capable of de novo cholesterol synthesis, and thus do not critically 
depend on milk for their cholesterol supply. As expected, infants fed cholesterol-free formula have increased cho-
lesterol synthesis rates compared to breast-fed infants36. Interestingly, however, adult individuals who had been 
breast-fed as infant have lower total and pro-atherogenic LDL-cholesterol compared to previously formula-fed 
subjects3. This has led to the hypothesis that early life cholesterol supply can program cholesterol homeostasis in 
later life. In support of this notion, we recently reported indications that dietary cholesterol availability in early life 
of mice determines the set-point for cholesterol absorption efficiency at adult age7. The rather strictly regulated 
concentration of milk cholesterol found in this study could support the relevance of a stable cholesterol supply for 
Figure 3. Mammary gland and milk cholesterol. (a) The lipid content of mammary tissue was extracted 
according to Bligh & Dyer and measured by gas chromatography (WT Chow, n = 5; WT HC, n = 5; Abcg8 
−/− Chow, n = 4; Abcg8 −/− HC, n = 5; Ldlr −/− Chow, n = 8; Ldlr −/− HC, n = 5). (b) Milk samples were 
obtained after i.p. injection with 1 IU oxytocin by using a modified electric human breast pump. Milk lipids 
were extracted according to Bligh & Dyer and cholesterol was quantified by gas chromatography (WT Chow, 
n = 5; WT HC, n = 5; Abcg8 −/− Chow, n = 4; Abcg8 −/− HC, n = 4; Ldlr −/− Chow, n = 6; Ldlr −/− HC, 
n = 3). Data are presented as median and interquartile range (Tukey). □: low cholesterol diet (Chow); ■: high 
cholesterol diet (HC). Statistical significance was assessed with Kruskal-Wallis post-hoc Conover-Inman test; 
non-different groups share a letter. The threshold of significance was p < 0.05.
www.nature.com/scientificreports/
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its programming importance. Third, a stable supply of dietary cholesterol could theoretically be relevant for the 
development of intestinal microbiota in early life. The cholesterol synthesis rate, the biliary cholesterol secretion 
and the fecal cholesterol excretion have all been shown to correlate with abundance of certain bacterial taxa in 
hamsters37. Additionally, conversion of cholesterol to the neutral sterol coprostanol by the intestinal microbiota 
is delayed in breast-fed infants38, indicating inhibited growth of certain bacterial groups. Yet, a recent study by 
ourselves in (adult) LDLR-deficient mice does not support the concept that dietary cholesterol has a substantial 
impact on shaping the intestinal microbiota, since neither the composition nor the functionality of the intestinal 
microbiota were affected even after prolonged dietary cholesterol exposure39.
In conclusion, our results clearly demonstrate that milk cholesterol levels are resistant to maternal high choles-
terol diet- and genetically-induced hypercholesterolaemia in mice. We speculate that the robust maintenance of 
stable milk cholesterol levels may serve relevant physiological functions in the offspring, such as programming of 
long-term health benefits. Further research however, is required to firmly establish such cause-effect relationships.
Figure 4. De novo cholesterol synthesis. On L14 the dams received deuterium water i.p. one hour before 
harvesting the organs. The mammary gland was milked 10 minutes before harvesting. The fraction of 
deuterium-incorporated cholesterol in liver and mammary gland was assessed using isotope ratio mass 
spectrometry (IRMS). (a) De novo cholesterol synthesis in the liver (%/h). (b) De novo cholesterol synthesis in 
the mammary gland (%/h). (WT Chow, n = 5; WT HC, n = 4; Abcg8 −/− Chow, n = 4; Abcg8 −/− HC, n = 5; 
Ldlr −/− Chow, n = 6; Ldlr −/− HC, n = 4). Data are presented as median and interquartile range (Tukey). 
Statistical significance was tested with Kruskal-Wallis post-hoc Conover-Inman; non-different groups share a 
letter. □: low cholesterol diet (Chow); ■: high cholesterol diet (HC). The threshold of significance was p < 0.05.
www.nature.com/scientificreports/
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Materials and Methods
Animal studies. Female C57BL/6J (n = 10), Ldlr knockout40 (n = 13) and Abcg8 knockout20,41 (n = 9) mice 
were housed in temperature controlled-conditions with 12:12 light dark cycles and maintained on chow diet 
(RMH-B, ABDiets, Woerden, Netherlands) with listed specified ingredients: wheat, meat meal, yellow dent corn, 
whole oats, wheat middlings, alfalfa, soya oil, dried yeast, dicalcium phosphate, calcium carbonate, NaCl, dl-me-
thionine, vitamins and trace elements. Breeding was initiated between 8–12 weeks of age. Due to accumulation 
of dietary xenosterols, Abcg8−/− mice are infertile, which is relieved upon ezetimibe treatment42. Therefore, in 
order to facilitate fertilization, Abcg8−/− females were pre-treated for 3 weeks with 0.005% ezetimibe provided 
via the food, which was removed from the diet once pregnancy was confirmed in accordance with Solca et al.42. 
The rest of the models were fed chow until E18, when half of the mice received 0.5% cholesterol diet. Lactation 
day 1 (L1) was considered the day at which pups were born. On L14 the dams were injected i.p. with 2.3 mL 99% 
2H2O (deuterium oxide) per 100 g BW, containing 0.9% NaCl. After 50 minutes, milk was collected for 10 minutes 
(details see below) directly followed by termination and harvesting of blood, liver, and mammary glands. All 
animal experiments were approved by the ethical committee for animal experimentation at the University of 
Groningen and performed in accordance with relevant guidelines and regulations.
Milk collection. At lactation day 1443, the dams were separated from the pups for 3 hours followed by i.p. 
injection of 1 IU oxytocin (Synthocinon®, Sigma-Tau Industrie Farmaceutiche Riunite, Rome, Italy). Milk sam-
ples were collected continuously for 10 minutes from the mammary gland of isoflurane-anesthetized mouse with 
the aid of a modified human electric breast pump (Calypso, Ardo Medical AG, Unterägeri, Switzerland). The 
samples were initially preserved at 4 °C during collection and further stored at −80 °C until use.
Determination of milk cholesterol. Thawed milk samples were homogenized by continuous vortexing. 
25 to 50 µL of milk sample was subjected to lipid extraction according to Bligh & Dyer44. Unesterified cholesterol 
was subsequently derivatized to cholesteryl acetate and quantified by gas chromatography, using 5-alpha choles-
tane as internal standard45.
Total plasma cholesterol and lipoprotein profiles. Total plasma cholesterol was measured enzymati-
cally using a commercially available kit (Roche Diagnostics GmbH, Mannheim, Germany). Lipoprotein fractions 
of pooled plasma samples (n = 3–5) were separated via fast protein liquid chromatography gel filtration using a 
superose 6 column (GE Healthcare, Little Chalfont, UK) as published46. Samples were chromatographed at a flow 
rate of 0.5 ml/min, and lipoprotein fractions of 500 μl each were collected. Individual fractions were assayed for 
cholesterol concentrations using a commercial kit (Roche Diagnostics GmbH, Mannheim, Germany).
Hepatic and mammary gland total cholesterol quantification. Liver and mammary gland tissues 
were homogenized using RNAse free-beads and the TissueLyser LT system (Qiagen GmbH, Hilden, Germany). 
Lipids were extracted according to Bligh & Dyer44. Cholesterol was de-esterified according to Ichihara et al.47. 
Free cholesterol underwent acetylation followed by quantification using gas chromatography (GC, Agilent 6890, 
Amstelveen, the Netherlands)45.
Organ-specific de novo cholesterol synthesis. Liver- and mammary gland-specific de novo cholesterol 
synthesis was quantified using the deuterium incorporation method48. Briefly, at L14 the dams were injected 
i.p. with deuterated water (2.3 mL/100 g BW, 99% 2H2O, 0.9% NaCl) and terminated after 60 minutes by cardiac 
puncture49. We used a non-injected control mouse for determining the number of hydrogen atoms incorpo-
rated in a single newly synthesized cholesterol molecule as measured by GC-MS. Following lipid extraction and 
de-esterification, the abundance of deuterium-substituted hydrogen atoms was determined by isotope ratio mass 
spectrometry (IRMS). Synthesis rates were determined as previously published50.
Statistical analysis. The significance of dietary influence within the different genotypes and the analysis 
of variance between genotypes in the same dietary condition was performed with Kruskal-Wallis followed by a 
multiple comparisons adjustment using Conover-Inman test. P-values below 0.05 were considered significant.
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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